Skip to content
Clinical Trials for Alzheimer's Disease

Illinois

Alzheimer's disease clinical trials in Illinois

21 Alzheimer's disease studies are recruiting participants at sites in 8 cities across Illinois as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Illinois city with a recruiting study

Chicago (14), Evanston (3), Elk Grove Village (2), Park Ridge (2), Aurora (1), Northbrook (1), Palos Hills (1), Springfield (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Illinois

Basic details from each study's public record (the 12 most recently updated of 21). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Chicago
    Registry record
    NCT07177352 · updated
  2. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    • Phase 3
    • Ages 55 to 80
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Chicago
    Registry record
    NCT07717411 · updated
  3. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Chicago
    Registry record
    NCT07602582 · updated
  4. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Chicago · Elk Grove Village
    Registry record
    NCT06976216 · updated
  5. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Elk Grove Village
    Registry record
    NCT07033494 · updated
  6. A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

    • Phase 4
    • Ages 50 and older
    • All sexes
    Sponsor
    Alpha Cognition, Inc
    Recruiting in
    Northbrook · Palos Hills
    Registry record
    NCT07633470 · updated
  7. CommunityRx-Dementia + Peer Navigation (CRxDpeer)

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Chicago
    Recruiting in
    Chicago
    Registry record
    NCT07346183 · updated
  8. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Chicago · Springfield
    Registry record
    NCT06976203 · updated
  9. OTC Hearing Aid and MCI

    • No phase
    • Ages 60 to 90
    • All sexes
    Sponsor
    Northwestern University
    Recruiting in
    Evanston
    Registry record
    NCT06112860 · updated
  10. Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music

    • No phase
    • Ages 55 and older
    • All sexes
    Sponsor
    Northwestern University
    Recruiting in
    Chicago
    Registry record
    NCT07775625 · updated
  11. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Recruiting in
    Chicago
    Registry record
    NCT06563895 · updated
  12. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Recruiting in
    Park Ridge
    Registry record
    NCT05552157 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Illinois on ClinicalTrials.gov.

Ask about studies in Illinois

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call